Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,156Revenue $M231Net Margin (%)1.8Altman Z-Score8.1
Enterprise Value $M2,106EPS $0.1Operating Margin %5.2Piotroski F-Score7
P/E(ttm)530Beneish M-Score-2.5Pre-tax Margin (%)1.9Higher ROA y-yY
Price/Book11.110-y EBITDA Growth Rate %--Quick Ratio1.2Cash flow > EarningsY
Price/Sales9.95-y EBITDA Growth Rate %--Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)1.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)2.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M36.7ROIC % (ttm)8.7Gross Margin Increase y-yY

Gurus Latest Trades with PCRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PCRXGeorge Soros 2015-06-30 Buy 0.39%$65.78 - $92.39
($78.91)
$ 58.82-25%New holding531,800
PCRXRon Baron 2015-06-30 Sold Out -0.03%$65.78 - $92.39
($78.91)
$ 58.82-25%Sold Out0
PCRXMariko Gordon 2015-06-30 Add0.02%$65.78 - $92.39
($78.91)
$ 58.82-25%Add 1.19%667,877
PCRXJoel Greenblatt 2015-06-30 Sold Out -0.01%$65.78 - $92.39
($78.91)
$ 58.82-25%Sold Out0
PCRXMariko Gordon 2015-03-31 Reduce-0.12%$85.01 - $119.27
($101.46)
$ 58.82-42%Reduce 4.30%659,998
PCRXGeorge Soros 2015-03-31 Sold Out -0.084%$85.01 - $119.27
($101.46)
$ 58.82-42%Sold Out0
PCRXJoel Greenblatt 2015-03-31 Buy 0.01%$85.01 - $119.27
($101.46)
$ 58.82-42%New holding9,319
PCRXRon Baron 2015-03-31 Add0.01%$85.01 - $119.27
($101.46)
$ 58.82-42%Add 22.79%82,380
PCRXMariko Gordon 2014-12-31 Reduce-0.54%$86.02 - $107.8
($94.65)
$ 58.82-38%Reduce 15.33%689,628
PCRXGeorge Soros 2014-12-31 Buy 0.08%$86.02 - $107.8
($94.65)
$ 58.82-38%New holding87,000
PCRXJoel Greenblatt 2014-12-31 Sold Out -0.01%$86.02 - $107.8
($94.65)
$ 58.82-38%Sold Out0
PCRXKen Fisher 2014-12-31 Buy $86.02 - $107.8
($94.72)
$ 58.82-38%New holding4,800
PCRXMariko Gordon 2014-09-30 Reduce-1.21%$83.31 - $108.26
($97.65)
$ 58.82-40%Reduce 28.09%814,470
PCRXRon Baron 2014-09-30 Reduce-0.03%$83.31 - $108.26
($97.65)
$ 58.82-40%Reduce 59.75%62,139
PCRXJoel Greenblatt 2014-09-30 Reduce$83.31 - $108.26
($97.65)
$ 58.82-40%Reduce 26.78%6,946
PCRXMariko Gordon 2014-06-30 Reduce-0.66%$63.61 - $91.01
($75.89)
$ 58.82-22%Reduce 17.39%1,132,552
PCRXRon Baron 2014-06-30 Add0.05%$63.61 - $91.01
($75.89)
$ 58.82-22%Add 802.88%154,393
PCRXJoel Greenblatt 2014-06-30 Buy 0.01%$63.61 - $91.01
($75.89)
$ 58.82-22%New holding9,486
PCRXMariko Gordon 2014-03-31 Add0.19%$55.83 - $80.43
($67.63)
$ 58.82-13%Add 5.13%1,371,042
PCRXRon Baron 2014-03-31 Add$55.83 - $80.43
($67.63)
$ 58.82-13%Add 163.28%17,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PCRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HASTINGS PAUL JDirector 2015-08-17Sell3,000$60.02-3.45view
STACK DAVID MPresident, CEO and Chairman 2015-07-15Sell15,000$67.78-14.5view
STACK DAVID MPresident, CEO and Chairman 2015-04-15Sell25,000$90.5-35.97view
HASTINGS PAUL JDirector 2015-04-10Sell2,500$88-34.15view
Riker Lauren BullaroExecutive Director, Finance 2015-03-16Sell5,000$95.34-39.22view
PACE GARY WDirector 2015-03-13Buy1,000$93.83-38.24view
LONGENECKER JOHN P PHDDirector 2015-03-12Sell3,000$95.28-39.18view
Scibetta James SSVP, CFO 2015-02-06Sell15,000$111.22-47.9view
STACK DAVID MPresident, CEO and Chairman 2015-01-15Sell15,000$97.52-40.58view
HASTINGS PAUL JDirector 2015-01-12Sell2,500$94.06-38.39view

Press Releases about PCRX :

Quarterly/Annual Reports about PCRX:

    News about PCRX:

    Articles On GuruFocus.com
    Wedbush Highlights 2015 Catalysts for Emerging BioPharmaceuticals Feb 04 2015 
    SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Pacira Pharmace Nov 28 2014 
    Mariko Gordon's First Quarter Top Five May 15 2014 
    Baron Funds Comments on Pacira Pharmaceuticals Mar 05 2014 
    comment on PCRX Mar 15 2013 
    Weekly CFO Buys Highlight: PCRX, UGI, MIG, GLT, IOSP Feb 27 2011 
    Weekly CFO Buys Highlight: REFR, UGI, PCRX, NOIZ Feb 21 2011 
    Pacira Pharmaceuticals Inc. (PCRX) CFO James S Scibetta buys 5,000 Shares Feb 16 2011 
    Pacira Pharmaceuticals Inc. (PCRX) CEO David M Stack buys 5,000 Shares Feb 11 2011 

    More From Other Websites
    Pacira Pharmaceuticals, Inc. Q2 Earnings, 2015 Aug 25 2015
    PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Aug 19 2015
    Pacira Pharmaceuticals Appoints James B. Jones, MD, PharmD, as Senior Vice President and Chief... Aug 19 2015
    Bluebird, Pacira Pharmaceuticals Excite Life Science Investors Aug 12 2015
    Baker Bros. Advisors Buys More DBV Technologies S.A. (DBVT); Visium Asset Management Goes Long On... Aug 11 2015
    PACIRA PHARMACEUTICALS, INC. Financials Aug 06 2015
    Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in August Aug 03 2015
    10-Q for Pacira Pharmaceuticals, Inc. Aug 01 2015
    Pacira Missed Q2 Earnings and Revenues, Exparel in Focus - Analyst Blog Jul 31 2015
    Pacira Pharma upgraded by BofA/Merrill Jul 31 2015
    Pacira Pharmaceuticals (PCRX) in Focus: Stock Jumps 5.3% - Tale of the Tape Jul 31 2015
    Edited Transcript of PCRX earnings conference call or presentation 30-Jul-15 1:00pm GMT Jul 30 2015
    Pacira meets 2Q profit forecasts Jul 30 2015
    Pacira meets 2Q profit forecasts Jul 30 2015
    PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 30 2015
    Pacira Pharmaceuticals, Inc. Reports Second Quarter 2015 Financial Results Jul 30 2015
    Animal Health Partner, Aratana Therapeutics, Announces Positive Pivotal Results for Controlling... Jul 15 2015
    Pacira Pharmaceuticals Announces Timing for Second Quarter 2015 Financial Results Webcast and... Jul 14 2015
    Aratana Therapeutics Announces Positive Pivotal Results for AT-003 Jul 14 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK